16-75204850-C-T

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001025200.4(CTRB2):​c.553G>A​(p.Glu185Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000016 ( 0 hom., cov: 19)
Exomes 𝑓: 0.000065 ( 3 hom. )

Consequence

CTRB2
NM_001025200.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.588
Variant links:
Genes affected
CTRB2 (HGNC:2522): (chymotrypsinogen B2) This gene encodes a member of the serine protease family of enzymes and forms a principal precursor of the pancreatic proteolytic enzymes. The encoded preproprotein is synthesized in the acinar cells of the pancreas and secreted into the small intestine where it undergoes proteolytic activation to generate a functional enzyme. This CTRB2 gene is located head-to-head with the related CTRB1 gene. Some human populations have an alternate haplotype which inverts a 16.6 Kb region containing portions of intron 1, exon 1, and the upstream sequence of the CTRB1 and CTRB2 genes. In this inversion haplotype exon 1 and flanking sequence is swapped in CTRB1 and CTRB2. This inversion is associated with differential gene expression and increased risk for chronic pancreatitis. The GRCh38 assembly represents the minor allele for SNP rs8048956 of the CTRB1 gene. SNP rs8048956 is diagnostic for this inversion. [provided by RefSeq, Jan 2021]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17223108).
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CTRB2NM_001025200.4 linkuse as main transcriptc.553G>A p.Glu185Lys missense_variant 6/7 ENST00000303037.13 NP_001020371.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CTRB2ENST00000303037.13 linkuse as main transcriptc.553G>A p.Glu185Lys missense_variant 6/71 NM_001025200.4 ENSP00000303963 P1

Frequencies

GnomAD3 genomes
AF:
0.0000157
AC:
2
AN:
127040
Hom.:
0
Cov.:
19
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000281
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000172
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000148
AC:
2
AN:
135268
Hom.:
1
AF XY:
0.0000278
AC XY:
2
AN XY:
71898
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000410
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000652
AC:
77
AN:
1181046
Hom.:
3
Cov.:
18
AF XY:
0.0000665
AC XY:
39
AN XY:
586092
show subpopulations
Gnomad4 AFR exome
AF:
0.0000353
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000215
Gnomad4 NFE exome
AF:
0.0000788
Gnomad4 OTH exome
AF:
0.0000794
GnomAD4 genome
AF:
0.0000157
AC:
2
AN:
127040
Hom.:
0
Cov.:
19
AF XY:
0.0000328
AC XY:
2
AN XY:
60948
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000281
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000172
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000843
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 25, 2024The c.553G>A (p.E185K) alteration is located in exon 6 (coding exon 6) of the CTRB2 gene. This alteration results from a G to A substitution at nucleotide position 553, causing the glutamic acid (E) at amino acid position 185 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
11
DANN
Benign
0.77
DEOGEN2
Benign
0.41
T;.;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.54
T;T;T
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.17
T;T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
1.3
L;.;.
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.6
N;N;N
REVEL
Benign
0.28
Sift
Benign
0.28
T;T;T
Sift4G
Benign
0.55
T;T;T
Polyphen
0.0020
B;.;.
Vest4
0.16
MutPred
0.49
Gain of MoRF binding (P = 0.0029);.;.;
MVP
0.47
MPC
0.11
ClinPred
0.071
T
GERP RS
-0.98
Varity_R
0.11
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1358591355; hg19: chr16-75238748; COSMIC: COSV100274780; API